US3809084A - Pressurized portable dispenser - Google Patents

Pressurized portable dispenser Download PDF

Info

Publication number
US3809084A
US3809084A US00224497A US22449772A US3809084A US 3809084 A US3809084 A US 3809084A US 00224497 A US00224497 A US 00224497A US 22449772 A US22449772 A US 22449772A US 3809084 A US3809084 A US 3809084A
Authority
US
United States
Prior art keywords
medicament
chamber
gas
dispenser
container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00224497A
Inventor
L Hansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Priority to US00224497A priority Critical patent/US3809084A/en
Application granted granted Critical
Publication of US3809084A publication Critical patent/US3809084A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001Particle size control
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0005Details of inhalators; Constructional features thereof with means for agitating the medicament
    • A61M15/0006Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means
    • A61M15/0008Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means rotating by airflow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0031Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up by bursting or breaking the package, i.e. without cutting or piercing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/82Internal energy supply devices
    • A61M2205/8218Gas operated
    • A61M2205/8225Gas operated using incorporated gas cartridges for the driving gas

Definitions

  • a portable powder dispensing device has a medicament chamber in which a dose of powdered medicament in anopen capsule shell is introduced and an outlet to cooperate with a human body cavity, such as a mouthpiece or, a nozzle for inserting in a nostril.
  • a jet of gas under pressure, from a propellant tank is introduced into the chamber at a swirl angle, The shell 1 containing the medicament vibrates and spins thereby breaking up the particles oraggregates.
  • a number of medicaments are introduced either orally or nasally.
  • nasal inhalators and there are also some devices for introducing finely divided medicament into the oral cavity and thence on into the respiratory system.
  • the nasal inhalator had a medicament chamber, openings to the atmosphere, and a nozzle which was introduced into the nostril. On inhaling, air was sucked into the chamber, picked up medicament, and was inhaled by the user.
  • the dispensers for the oral cavity not only had a different shaped mouthpiece but often had a container feeding into a venturi tube through which air or a gas flowed, picking up the medicament. Some used a squeeze bulb or compressed air source to suspend the powder. I
  • a medicament chamber into which gas or air under pressure is introduced at a swirl angle to create turbulence so that the entire dose in the chamber is carried oninto the body cavity, e.g., nose or mouth, and thence into the respiratory system, or vagina, ear or wound for local therapy.
  • An important feature is a loose element in the medicament chamber such as half of the shell of a capsule carrying a dose of medicament. This shell spins, vibrates and collides with the powdered medicament thus preventing the formation of or breaking up any coarser aggregates. Adhering of medicament to the'walls of the dispensing chamber is greatly reduced and for the most part completely eliminated, and more importantly is consistent for any given system.
  • the present invention permits discharging finely divided solid particles from an accurately predetermined dosage either into the nose or mouth or similar body cavity. No problem of over dosage is presented, which was a problem with some dispensers used in the past. With medicaments which in excessive amounts have undesirable effects, complete safety is assured.
  • the dispenser of the present invention at first glance appears somewhat similar to a nasal inhalator.
  • the air passages are scaled up and a gas duct carries gas under pressure into a side of the mixing chamber.
  • the swirl angle As the gas comes in at an angle, called the swirl angle, there is high turbulence and a very thorough distribution of the medicament results.
  • a measured dose of medicament is ordinarily introduced in a half of a capsule. The capsule half vibrates violently, which results in complete emptying of medicament dose and also breaks up aggregates, giving a fine aerosol or smoke, defined as a suspension of solid particles in gas.
  • the gas duct enters the medicamentchamher at an angle which is not a right angle.
  • the particular angle is not critical so long as it is a sufficient angle to produce a high degree of turbulence.
  • a liquid may be introduced in the capsule half shell, if the medicament is more'readily administered in liquid form.
  • the most important use for the present invention is to introduce a medicament into the respiratory system, but it is possible to introduce small doses of medicament into the nasal passages without their being driven into the lungs.
  • the nose and mouth are the cavities in which the dispensers of the present invention are primarily used, other bodily cavities can also receive accuratelypredetermined dosages of finely divided medicament; and therefore, in its broader aspects the present invention is not strictly limited to dispensers to be used in oral or nasal use.
  • the source of the gas under pressure is not a critical part of the present invention. It is convenient to form the gas introducing tube for the mixing chamber so that it can be pressed on the discharge valve of an ordinary aerosol container or pressure tank which contains a volatile liquid or gas, such as Freon, of suitable boiling point.
  • chlorodifluoromethane sold under trademarks such as Freon 12 or Genetron i2
  • Freon 12 or Genetron i2 is conveniently commercially obtainable in small pressure tanks having a depressable stem valve.
  • Such pressure tanks areused as power units for spray paints, noise devices, signal ing systems, and many other purposes.
  • dichlorodifluoromethane is essentially non-toxic. In larger quantities, it dilutes the oxygenin the air to such an extent that it can become suffocating.
  • Other propellants such as carbon dioxide in cylinders, or compressed air or compressed oxygen from tanks or a supply line may be used as a power source. Where fixed compressed gases such as oxygen or air are used as a power source,
  • dichlorodifiuoroniethane or other of the haloalkanes permits a very compact and readily portable package and may be considered as the preferred form of use of the invention. It should be understood that when the dispenser is pressed onto the discharge valve of a pressure tank it should be pressed for a short but sufficient time to assure that the full dosage of medicament in the dispensing chamber is ejected into the desired body cavity. This presents no problem as an exact time measurement is not needed.
  • FIG. 1 is a cross-section through a nasal inhalator of the present invention.
  • FIG. 2 is a cross-section through a nasal inhaler which fits axially on the pressure tank and discharges powder at an angle.
  • FIG. 3 is a cross-section on line 3-3 of FIG. 2 showing a cross-section of the dispenser, particularly the swirl angle of the gas duct.
  • FIG. 4 is a modification of the dispenser showing radial pressurization and axial discharge with threaded assembly.
  • FIG. 5 is a drawing on a smaller scale showing the use of a dilution chamber for the dispersed aerosol.
  • FIG. 6 is a cross-section of a simplified two-piece assembly in which the propellant tank feeds directly into the medicament chamber.
  • FIG. 7 is a cross-section along lines 77 of FIG. 6.
  • FIG. 1 shows a powder dispenser in which a gas duct 13, which at its other end attaches to the valve of the aerosol can or propellant tank 14 enters at a swirl angle into the medicament chamber 12 in the dispenser housing 11.
  • the nasal nozzle 15 is removed by unscrewing at the threaded nozzle coupling 16 and half of a hard shell capsule 17 containing a powdered medicament 18 is introduced into the medicament chamber 12.
  • the nasal nozzle 15 is then fastened on by screwing or by friction fit and the gas duct 13 is brought into contact with the valve stem 19 of an aerosol can or propellant tank 14.
  • Theblast of Freon enters at a swirl angle, causes high turbulence in the medicament chamber 12 which is further enhanced by the vibration and spinning of the half capsule 17, resulting in complete emptying thereof and in further turbulence, so that the whole dose of powdered medicament 18 is introducedthrough the nasal nozzle 15 into the nostril of the user.
  • the medicament to be dispensed may be any of the therapeutic agents which are desirably administered in finely divided powdered form. While not restricted to such powder size, materials having a particle size of 90 percent smaller than 5 microns are conveniently administered by the present type of portable powder dispenser. Larger powders may be administered, but usually less elegant techniques are satisfactory with the larger powders.
  • the finely powdered medicaments are penicillin or salts or derivatives thereof, steroids or a therapeutically effective salt or derivative thereof, and isoproternol as well as live virus materials. Some such live viruses materials are disclosed in US. Pat. No. 2,798,835, Markham and Cox, NEWCASTLE DISEASE AND INFECTIOUS BRONCHITIS VAC- CINES AND PRODUCTION THEREOF, and US.
  • live virus products may be administered to humans or other mammals.
  • the present type of dispenser is particularly advantageous with medicaments which are sensitive to moisture or storage conditions.
  • the medicament may be stored under conditions most advantageous for storage, and yet readily transferred to the present dission on administration.
  • FIG. 2 An axial-feed, angular-dispensing modification of the invention is shown in FIG. 2.
  • the dispenser housing 21 is a massive plastic block in which is formed the medicament chamber 22.
  • a gas duct 23 is formed in the dispenser housing, conveniently by drilling, so that one wall is nearly tangent to the medicament chamber, as shown in FIG. 3. This gives a highly effective swirl angle so that 'as the dispersing propellant is introduced into the medicament chamber a high degree of spin and turbulence is attained.
  • the nasal nozzle 25 is a press fit into the medicament chamber and has a discharge duct 26 leading axially from the medicament chamber, with a bend of approximately 45, so that the finely divided powder being dispersed is dispensed at a convenient angle for oral or nasal administration.
  • Half of a hard shell capsule 27 containing a powdered medicament 28 fits into the medicament chamber 22 to be dispersed at time of use.
  • the inner chamber is for the inner chamber to beabout 0.28 inches in diameter and about 0.5 inch depth with a radius at the bottom of the chamber.
  • the larger portion of a number 5 hard shell capsule which is approximately 0.38 inches long and approximately 0.19 inches in diameter fits loosely into the medicament chamber. With this size, the half of a hard shell capsule cannot turn over but is maintained in a somewhat upright position where it can rotate and vibrate but not turn over. If the chamber diameter is too small, the half capsule shell forming the medicament container will not rotate and vibrate and if it is too large, the capsule shell can become tilted and jammed and hence prevent rotation.
  • the gas pressure through the gas duct should be such that the half capsule shell has a high rotational velocity, but not so high as to fracture.
  • the half capsule shell itself may be disintegrated. Stroboscopic observation shows that a rotational and vibrational rate of about 1,200 to 2,000 cycles per minute gives excellent results. For such rotational speeds the rotation and vibration dislodges the finely divided powder from the capsule shell, causing the powder to be picked up by the moving gas, and the entire suspension, now known as an aerosol or smoke, is discharged through the discharge duct for administration, such as inhalation by the subject.
  • the orifice can be adapted to suit the site of application, for instance the mouth, the ear, the vagina, or a surface to which th powder is to be applied.
  • the dispenser housing is shown as fittin'g tightly into an outer dispenser holder 29.
  • the space between the outer dispenser holder 29 and the-dispenser housing 21 acts as a damping chamber 30 which smooths out any vibrations or variations in the propellant flow, aids in preventing liquid portions of the propellant being fed into themedicament chamber, and enhances smooth operation.
  • a pressure chamber adapter 31 has a size and shape to fit over the stem 32 of a discharge valve on a propellant tank 24. Conveniently the pressure chamber adapter has a size such that from about 10 to about 15 cubic feet per minute of propellant gas flow into the damping chamber.
  • the size of the pressure chamber adapter is critical to the extent that it must fit smoothly over the stem of the dispensing valve on the propellant tank without excess gas leakage but other than mating to each other, there are no critical limitations on such dimensions.
  • the pressure chamber adapter fits current commercial valve stem standards.
  • FIG. 4 is shown a modification in which the dispenser housing 34 has female threads 35 to receive male threads 36 on the end of an axial nasal nozzle 37. In this configuration, there is less chance of the nasal nozzle being blown out of the medicament chamber 38.
  • the dispenser housing 34 is also adapted to be retained by screw threads 39 in the outer dispenser holder 40.
  • a pressure adapter 41 fits over the stem 42 of the valve on a propellant tank 43.
  • the propellant tank and stem are radial, and hence adaptedto be held vertically while the nasal nozzle 37 is held horizontal to dispense a medicament into the mouth, ear or nose of a user. Because of the nature of the device, the complete assembly may be held in any angle which is convenient for administration.
  • Some valves on, the propellant tank operate more effectively if held above the surface of any propellant in the tank which may be in liquid form, but other valves work satisfactorily when held in any position.
  • FIG. 5 A modification of the axial flow device in FIG. 4 is shown in FIG. 5 in which a shoulder 45 is formed on the dispenser housing 34 to cooperate with a dilution chamber 46.
  • the dilution chamber is a hollow cylinder,
  • Vents 48 permit the flow of air into the dilution chamber.
  • the discharge end of the dilution chamber has a mouthpiece 49 which can fitinto the mouth of the user.
  • a dust cap 50 may be removably placed over the mouthpiece to keep it clean when not in use.
  • the dilution chamber permits the aerosol or smoke as it is emitted from the nozzle to be diluted with air, and aggregates or unground particles to settleout or fall against the wall of the dilution chamber, so that a more uniform, more dilute aerosol is served to the user whereby a deeper therapy is readily obtained by inhaling the smoke or aerosol deeper into the lungs.
  • Such a dilution chamber also aids in maintaining a uniform dosage. Part of the dose in the capsule shell is lost in the dilution chamber but as the portion lost is consistent, a more consistent dosage may be administered to the user. A small but consistent loss to give a more uniform dosage is advantageous with those medicaments for which the dosage level is critical.
  • FIGS. 6 and 7 A simplified modification is shown in FIGS. 6 and 7 in which the dispenser housing 52 is a single rectangular block having a medicament chamber 53 formed therein with screw threads to hold the nasal nozzle 54.
  • the nasal nozzle is axial with the medicament chamber and conveniently formed on automatic screw machines.
  • an offset is the pressure chamber adapter 55 which fits over the stem of a propellant tank, not shown, and which feeds the pressurizing gas directly into the medicament chamber where the gas spins the half hard shell capsule 56 containing the medicament 57.
  • This configuration may be smaller and lighter than those above shown and is thus adapted to be carried in the pocket of a user.
  • the assembly of a small pressure tank, the dispenser housing, the nasal nozzle and a supply of capsules containing medicaments may be put in a small case which fits into the pocket of and is carried by the user.
  • the top can be removed from the hard shell capsule, the half containing the medicament dropped into the medicament chamber, and the nasal nozzle screwed into retaining location, the stem of the pressure tank placed in the pressure chamber adapter, and a dose dispensed to the user with a minimum of time if the patient is subject to distress symptoms such that rapidity of administration becomes critical.
  • a dispenser system for introducing a finely powdered medicament into a body opening comprising, in combination:
  • a dispenser housing having therein a medicament chamber, and removably attached thereto,
  • a nozzle having one end shaped to cooperate with a body cavity, and the other end attached to said dispenser housing and closing the medicament chamber, and having a central discharge duct therethrough from end toend, M
  • said medicament chamber being adapted to hold a movable solid medicament container having therein a single powdered medicament dose which container vibrates and spins when gas under pres sure is introduced into said chamber thereby increasing the inherent swirl and turbulence due to the introduction of gas under pressure,
  • a medicament container about the size and shape of half of a hard shell capsule, adapted to move freely in but not turn over in said medicament chamber, and a predetermined single dose of a powdered medicament in said container,
  • At least one gas duct passing through the wall of said dispenser housing and entering nearly tangent to the medicament chamber for introducing gas under pressure into the medicament chamber at a swirl angle to the chamber, whereby turbulence results

Abstract

A portable powder dispensing device has a medicament chamber in which a dose of powdered medicament in an open capsule shell is introduced and an outlet to cooperate with a human body cavity, such as a mouthpiece or a nozzle for inserting in a nostril. A jet of gas under pressure, from a propellant tank is introduced into the chamber at a swirl angle. The shell containing the medicament vibrates and spins thereby breaking up the particles or aggregates.

Description

United States Patent 1191 Hansen 1111; 3,809,084 1 May 7, 1974 1 PRESSURIZED PORTABLE DISPENSER [75] Inventor: Lloyd Frank Hansen, Campbell Hall, N.Y.
[73] Assignee: American Cyanamid Company,
Stamford, Conn.
[22] Filed: Feb. 8, 1972 [21] Appl. No.: 224,497
Related US. Application Data [63] Continuation-impart of Ser. No. 11,555, Feb. 16,
1970, Pat. No. 3,653,380.
[52] US. Cl 128/266, 128/187, 222/190,
1 1 239/315 [51] Int. Cl. A611 13/00, A6lm 15/08 [58] Field of Search 128/172, 173, 185, 186,
[56] References Cited UNITED STATES PATENTS 7 2,533,065 12/1950 Taplin et a1 128/266 X 2,722,935 11/1955 Thompson et a1. 128/266 Ramis ..L 128/203 x 3,184,115 5/1965 Meshberg 128/173 R 3,357,427 12/1967 Wittke et a1. 128/260 X 2,642,063 6/1953 Brown 128/206 3,355,071 11/1967 Jordan 222/190 2,517,482 8/1950 Hall 128/206 2,992,645 7/1961 Fow1er..... 128/266 X 2,865,370 12/1958 Gattone 128/173 R Primary Examiner-Richard A. Gaudet Assistant Examiner-J. C. McGowan Attorney, Agent, or FirmSamuel Branch Walker [57] 7 ABSTRACT A portable powder dispensing device has a medicament chamber in which a dose of powdered medicament in anopen capsule shell is introduced and an outlet to cooperate with a human body cavity, such as a mouthpiece or, a nozzle for inserting in a nostril. A jet of gas under pressure, from a propellant tank is introduced into the chamber at a swirl angle, The shell 1 containing the medicament vibrates and spins thereby breaking up the particles oraggregates.
1 Claim, 7 Drawing Figures PATENTEDW H914 sum .1 0r 2 ATENTEDHAY 1 m4 3.809.084
SHEET 2 OF 2 fIE-5 1 PRESSURIZED PORTABLE DISPENSER CROSS REFERENCES This application is a continuation-in-part of copending application Ser. No. 11,555, filed Feb. 16, 1970, now.U.S. Pat. No. 3,653,380, dated Apr. 4, 1972. The references in the prosecution thereof are hereby incorporated by this reference thereto.
BACKGROUND OF THE INVENTION A number of medicaments are introduced either orally or nasally. For instance, there are a number of nasal inhalators and there are also some devices for introducing finely divided medicament into the oral cavity and thence on into the respiratory system. In the past there were two general types. The nasal inhalator had a medicament chamber, openings to the atmosphere, and a nozzle which was introduced into the nostril. On inhaling, air was sucked into the chamber, picked up medicament, and was inhaled by the user. The dispensers for the oral cavity not only had a different shaped mouthpiece but often had a container feeding into a venturi tube through which air or a gas flowed, picking up the medicament. Some used a squeeze bulb or compressed air source to suspend the powder. I
Wherethere was no reason to measure the dose accurately, these types of dispensers were quite satisfactory and are used on a large scale, particularly the nasal inhalators. It was difficult or impossible to introduce a definitely measured dose, with most of these devices.
It is with improved dispensing devices which can dispense' accurately measured doses that the present invention deals.
SUMMARY or THE iNvENTioN The present invention departs from prior designs in several important respects. First, there is a medicament chamber into which gas or air under pressure is introduced at a swirl angle to create turbulence so that the entire dose in the chamber is carried oninto the body cavity, e.g., nose or mouth, and thence into the respiratory system, or vagina, ear or wound for local therapy. An important feature is a loose element in the medicament chamber such as half of the shell of a capsule carrying a dose of medicament. This shell spins, vibrates and collides with the powdered medicament thus preventing the formation of or breaking up any coarser aggregates. Adhering of medicament to the'walls of the dispensing chamber is greatly reduced and for the most part completely eliminated, and more importantly is consistent for any given system.
The present invention permits discharging finely divided solid particles from an accurately predetermined dosage either into the nose or mouth or similar body cavity. No problem of over dosage is presented, which was a problem with some dispensers used in the past. With medicaments which in excessive amounts have undesirable effects, complete safety is assured.
In one form, the dispenser of the present invention at first glance appears somewhat similar to a nasal inhalator. However, the air passages are scaled up and a gas duct carries gas under pressure into a side of the mixing chamber. As the gas comes in at an angle, called the swirl angle, there is high turbulence and a very thorough distribution of the medicament results. A measured dose of medicament is ordinarily introduced in a half of a capsule. The capsule half vibrates violently, which results in complete emptying of medicament dose and also breaks up aggregates, giving a fine aerosol or smoke, defined as a suspension of solid particles in gas.
I Ordinarily the gas duct enters the medicamentchamher at an angle which is not a right angle. The particular angle is not critical so long as it is a sufficient angle to produce a high degree of turbulence. A liquid may be introduced in the capsule half shell, if the medicament is more'readily administered in liquid form. The most important use for the present invention is to introduce a medicament into the respiratory system, but it is possible to introduce small doses of medicament into the nasal passages without their being driven into the lungs. Also, while the nose and mouth are the cavities in which the dispensers of the present invention are primarily used, other bodily cavities can also receive accuratelypredetermined dosages of finely divided medicament; and therefore, in its broader aspects the present invention is not strictly limited to dispensers to be used in oral or nasal use. v
The source of the gas under pressure is not a critical part of the present invention. It is convenient to form the gas introducing tube for the mixing chamber so that it can be pressed on the discharge valve of an ordinary aerosol container or pressure tank which contains a volatile liquid or gas, such as Freon, of suitable boiling point.
,Chlorofluoroalkanes and mixtures of them give propellants with preferred pressure characteristics. Di-
chlorodifluoromethane, sold under trademarks such as Freon 12 or Genetron i2, is conveniently commercially obtainable in small pressure tanks having a depressable stem valve. Such pressure tanks areused as power units for spray paints, noise devices, signal ing systems, and many other purposes.
Inthe quantities used for powder dispensing, dichlorodifluoromethane is essentially non-toxic. In larger quantities, it dilutes the oxygenin the air to such an extent that it can become suffocating. Other propellants such as carbon dioxide in cylinders, or compressed air or compressed oxygen from tanks or a supply line may be used as a power source. Where fixed compressed gases such as oxygen or air are used as a power source,
the complexity of pressure reducing devices to give a uniform pressure for the dispensing of the medicament introduces a cost and weight that is unacceptable for some usages. For use in a doctors office or under hospital conditions where a large number of doses are to be dispensed and skilled maintenance is available and weight is not critical, such compressed gas, particularly oxygen, is quite advantageous as the oxygen can aid breathing performance and is frequently used in respiratory therapy to reduce the load on the heart and lungs, and is readily available.
The use of dichlorodifiuoroniethane or other of the haloalkanes permits a very compact and readily portable package and may be considered as the preferred form of use of the invention. It should be understood that when the dispenser is pressed onto the discharge valve of a pressure tank it should be pressed for a short but sufficient time to assure that the full dosage of medicament in the dispensing chamber is ejected into the desired body cavity. This presents no problem as an exact time measurement is not needed.
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a cross-section through a nasal inhalator of the present invention.
FIG. 2 is a cross-section through a nasal inhaler which fits axially on the pressure tank and discharges powder at an angle. I
FIG. 3 is a cross-section on line 3-3 of FIG. 2 showing a cross-section of the dispenser, particularly the swirl angle of the gas duct.
FIG. 4 is a modification of the dispenser showing radial pressurization and axial discharge with threaded assembly.
FIG. 5 is a drawing on a smaller scale showing the use of a dilution chamber for the dispersed aerosol.
FIG. 6 is a cross-section of a simplified two-piece assembly in which the propellant tank feeds directly into the medicament chamber.
FIG. 7 is a cross-section along lines 77 of FIG. 6.
DESCRIPTION OF PREFERRED EMBODIMENTS FIG. 1 shows a powder dispenser in which a gas duct 13, which at its other end attaches to the valve of the aerosol can or propellant tank 14 enters at a swirl angle into the medicament chamber 12 in the dispenser housing 11. In use, the nasal nozzle 15 is removed by unscrewing at the threaded nozzle coupling 16 and half of a hard shell capsule 17 containing a powdered medicament 18 is introduced into the medicament chamber 12. The nasal nozzle 15 is then fastened on by screwing or by friction fit and the gas duct 13 is brought into contact with the valve stem 19 of an aerosol can or propellant tank 14. Theblast of Freon enters at a swirl angle, causes high turbulence in the medicament chamber 12 which is further enhanced by the vibration and spinning of the half capsule 17, resulting in complete emptying thereof and in further turbulence, so that the whole dose of powdered medicament 18 is introducedthrough the nasal nozzle 15 into the nostril of the user.
The medicament to be dispensed may be any of the therapeutic agents which are desirably administered in finely divided powdered form. While not restricted to such powder size, materials having a particle size of 90 percent smaller than 5 microns are conveniently administered by the present type of portable powder dispenser. Larger powders may be administered, but usually less elegant techniques are satisfactory with the larger powders. Among the finely powdered medicaments are penicillin or salts or derivatives thereof, steroids or a therapeutically effective salt or derivative thereof, and isoproternol as well as live virus materials. Some such live viruses materials are disclosed in US. Pat. No. 2,798,835, Markham and Cox, NEWCASTLE DISEASE AND INFECTIOUS BRONCHITIS VAC- CINES AND PRODUCTION THEREOF, and US.
live virus products may be administered to humans or other mammals. The present type of dispenser is particularly advantageous with medicaments which are sensitive to moisture or storage conditions. The medicament may be stored under conditions most advantageous for storage, and yet readily transferred to the present dission on administration.
An axial-feed, angular-dispensing modification of the invention is shown in FIG. 2. Here the dispenser housing 21 is a massive plastic block in which is formed the medicament chamber 22. A gas duct 23 is formed in the dispenser housing, conveniently by drilling, so that one wall is nearly tangent to the medicament chamber, as shown in FIG. 3. This gives a highly effective swirl angle so that 'as the dispersing propellant is introduced into the medicament chamber a high degree of spin and turbulence is attained. The nasal nozzle 25 is a press fit into the medicament chamber and has a discharge duct 26 leading axially from the medicament chamber, with a bend of approximately 45, so that the finely divided powder being dispersed is dispensed at a convenient angle for oral or nasal administration. Half of a hard shell capsule 27 containing a powdered medicament 28 fits into the medicament chamber 22 to be dispersed at time of use.
One configuration which gives excellent results for powdered steroids is for the inner chamber to beabout 0.28 inches in diameter and about 0.5 inch depth with a radius at the bottom of the chamber. The larger portion of a number 5 hard shell capsule which is approximately 0.38 inches long and approximately 0.19 inches in diameter fits loosely into the medicament chamber. With this size, the half of a hard shell capsule cannot turn over but is maintained in a somewhat upright position where it can rotate and vibrate but not turn over. If the chamber diameter is too small, the half capsule shell forming the medicament container will not rotate and vibrate and if it is too large, the capsule shell can become tilted and jammed and hence prevent rotation. The gas pressure through the gas duct should be such that the half capsule shell has a high rotational velocity, but not so high as to fracture. If too much pressure is fed in, the half capsule shell itself may be disintegrated. Stroboscopic observation shows that a rotational and vibrational rate of about 1,200 to 2,000 cycles per minute gives excellent results. For such rotational speeds the rotation and vibration dislodges the finely divided powder from the capsule shell, causing the powder to be picked up by the moving gas, and the entire suspension, now known as an aerosol or smoke, is discharged through the discharge duct for administration, such as inhalation by the subject.
While shown as a nasal nozzle, the orifice can be adapted to suit the site of application, for instance the mouth, the ear, the vagina, or a surface to which th powder is to be applied.
The dispenser housing is shown as fittin'g tightly into an outer dispenser holder 29. The space between the outer dispenser holder 29 and the-dispenser housing 21 acts as a damping chamber 30 which smooths out any vibrations or variations in the propellant flow, aids in preventing liquid portions of the propellant being fed into themedicament chamber, and enhances smooth operation. A pressure chamber adapter 31 has a size and shape to fit over the stem 32 of a discharge valve on a propellant tank 24. Conveniently the pressure chamber adapter has a size such that from about 10 to about 15 cubic feet per minute of propellant gas flow into the damping chamber. The size of the pressure chamber adapter is critical to the extent that it must fit smoothly over the stem of the dispensing valve on the propellant tank without excess gas leakage but other than mating to each other, there are no critical limitations on such dimensions. Preferably the pressure chamber adapter fits current commercial valve stem standards.
In FIG. 4 is shown a modification in which the dispenser housing 34 has female threads 35 to receive male threads 36 on the end of an axial nasal nozzle 37. In this configuration, there is less chance of the nasal nozzle being blown out of the medicament chamber 38. The dispenser housing 34 is also adapted to be retained by screw threads 39 in the outer dispenser holder 40. A pressure adapter 41 fits over the stem 42 of the valve on a propellant tank 43. Here the propellant tank and stem are radial, and hence adaptedto be held vertically while the nasal nozzle 37 is held horizontal to dispense a medicament into the mouth, ear or nose of a user. Because of the nature of the device, the complete assembly may be held in any angle which is convenient for administration. Some valves on, the propellant tank operate more effectively if held above the surface of any propellant in the tank which may be in liquid form, but other valves work satisfactorily when held in any position.
A modification of the axial flow device in FIG. 4 is shown in FIG. 5 in which a shoulder 45 is formed on the dispenser housing 34 to cooperate with a dilution chamber 46. The dilution chamber is a hollow cylinder,
conveniently with a housing coupling 47 which fits over and against the shoulder 45 to hold the dilution chamher in position. Vents 48 permit the flow of air into the dilution chamber. The discharge end of the dilution chamber has a mouthpiece 49 which can fitinto the mouth of the user. A dust cap 50 may be removably placed over the mouthpiece to keep it clean when not in use.
In use, the dilution chamber permits the aerosol or smoke as it is emitted from the nozzle to be diluted with air, and aggregates or unground particles to settleout or fall against the wall of the dilution chamber, so that a more uniform, more dilute aerosol is served to the user whereby a deeper therapy is readily obtained by inhaling the smoke or aerosol deeper into the lungs. Such a dilution chamber also aids in maintaining a uniform dosage. Part of the dose in the capsule shell is lost in the dilution chamber but as the portion lost is consistent, a more consistent dosage may be administered to the user. A small but consistent loss to give a more uniform dosage is advantageous with those medicaments for which the dosage level is critical.
A simplified modification is shown in FIGS. 6 and 7 in which the dispenser housing 52 is a single rectangular block having a medicament chamber 53 formed therein with screw threads to hold the nasal nozzle 54. The nasal nozzle is axial with the medicament chamber and conveniently formed on automatic screw machines. At right angles an offset is the pressure chamber adapter 55 which fits over the stem of a propellant tank, not shown, and which feeds the pressurizing gas directly into the medicament chamber where the gas spins the half hard shell capsule 56 containing the medicament 57. This configuration may be smaller and lighter than those above shown and is thus adapted to be carried in the pocket of a user.
.The assembly of a small pressure tank, the dispenser housing, the nasal nozzle and a supply of capsules containing medicaments may be put in a small case which fits into the pocket of and is carried by the user. For such uses, it is convenient to have the other half of the hard shell capsule emplaced over the half containing the medicament so that a complete hard shell capsule is carried by the user and opened just priorto administration. The top can be removed from the hard shell capsule, the half containing the medicament dropped into the medicament chamber, and the nasal nozzle screwed into retaining location, the stem of the pressure tank placed in the pressure chamber adapter, and a dose dispensed to the user with a minimum of time if the patient is subject to distress symptoms such that rapidity of administration becomes critical.
Other modifications of the present powder dispenser are within the scope of the invention which is defined by the following claims:
I claim:
l. A dispenser system for introducing a finely powdered medicament into a body opening, comprising, in combination:
a dispenser housing having therein a medicament chamber, and removably attached thereto,
a nozzle having one end shaped to cooperate with a body cavity, and the other end attached to said dispenser housing and closing the medicament chamber, and having a central discharge duct therethrough from end toend, M
said medicament chamber being adapted to hold a movable solid medicament container having therein a single powdered medicament dose which container vibrates and spins when gas under pres sure is introduced into said chamber thereby increasing the inherent swirl and turbulence due to the introduction of gas under pressure,
in said medicament chamber a medicament container about the size and shape of half of a hard shell capsule, adapted to move freely in but not turn over in said medicament chamber, and a predetermined single dose of a powdered medicament in said container,
at least one gas duct passing through the wall of said dispenser housing and entering nearly tangent to the medicament chamber for introducing gas under pressure into the medicament chamber at a swirl angle to the chamber, whereby turbulence results,
means to introduce gas under pressure through said gas duct, whereby said powdered medicament in said container is efficiently dispersed in the turbulent gas and essentially completelyadministered at duct into the medicament chamber.

Claims (1)

1. A dispenser system for introducing a finely powdered medicament into a body opening, comprising, in combination: a dispenser housing having therein a medicament chamber, and removably attached thereto, a nozzle having one end shaped to cooperate with a body cavity, and the other end attached to said dispenser housing and closing the medicament chamber, and having a central discharge duct therethrough from end to end, said medicament chamber being adapted to hold a movable solid medicament container having therein a single powdered medicament dose which container vibrates and spins when gas under pressure is introduced into said chamber thereby increasing the inherent swirl and turbulence due to the introduction of gas under pressure, in said medicament chamber a medicament container about the size and shape of half of a hard shell capsule, adapted to move freely in but not turn oVer in said medicament chamber, and a predetermined single dose of a powdered medicament in said container, at least one gas duct passing through the wall of said dispenser housing and entering nearly tangent to the medicament chamber for introducing gas under pressure into the medicament chamber at a swirl angle to the chamber, whereby turbulence results, means to introduce gas under pressure through said gas duct, whereby said powdered medicament in said container is efficiently dispersed in the turbulent gas and essentially completely administered at a single time of use, into the body cavity, said means including an outer dispenser holder attached to said dispenser housing surrounding said gas duct and spaced from a portion of said dispenser housing forming a damping chamber between said outer dispenser holder and the dispenser housing, and a pressure chamber adapter passing through said outer dispenser holder to receive the stem of a dispensing compressed gas propellant tank, thereby permitting pressurization of the damping chamber, and the damped transfer of gas pressure through the gas duct into the medicament chamber.
US00224497A 1970-02-16 1972-02-08 Pressurized portable dispenser Expired - Lifetime US3809084A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US00224497A US3809084A (en) 1970-02-16 1972-02-08 Pressurized portable dispenser

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1155570A 1970-02-16 1970-02-16
US00224497A US3809084A (en) 1970-02-16 1972-02-08 Pressurized portable dispenser

Publications (1)

Publication Number Publication Date
US3809084A true US3809084A (en) 1974-05-07

Family

ID=26682523

Family Applications (1)

Application Number Title Priority Date Filing Date
US00224497A Expired - Lifetime US3809084A (en) 1970-02-16 1972-02-08 Pressurized portable dispenser

Country Status (1)

Country Link
US (1) US3809084A (en)

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888252A (en) * 1974-01-23 1975-06-10 Anthony J Side Powder inhaler
US3998226A (en) * 1975-09-22 1976-12-21 Edward G. Gomez Inhalation device for encapsulated concentrates
EP0009667A1 (en) * 1978-09-11 1980-04-16 Michael T. Dr. Newhouse Inhalation device
US4687034A (en) * 1986-05-28 1987-08-18 Shell Oil Company Controlled release insert for a diesel fuel supply nozzle and method of adding a petroleum substrate over said insert
EP0271029A2 (en) * 1986-12-05 1988-06-15 Mect Corporation Inhaler
US4796812A (en) * 1986-03-24 1989-01-10 L'oreal Device for preparing and dispensing a product consisting of two components and the corresponding process
US4841964A (en) * 1985-08-01 1989-06-27 Wilhelm Hurka Inhaler
US4940051A (en) * 1983-12-28 1990-07-10 Huhtamki Oy Inhalation device
EP0377174A2 (en) * 1988-12-22 1990-07-11 Büsselmann, Manfred Method and apparatus for spraying and atomising liquids
US5161524A (en) * 1991-08-02 1992-11-10 Glaxo Inc. Dosage inhalator with air flow velocity regulating means
US5388573A (en) * 1993-12-02 1995-02-14 Tenax Corporation Dry powder inhalator medicament carrier
US5388572A (en) * 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5460173A (en) * 1993-03-03 1995-10-24 Tenax Corporation Dry powder inhaler medicament carrier
US5476093A (en) * 1992-02-14 1995-12-19 Huhtamaki Oy Device for more effective pulverization of a powdered inhalation medicament
US6029661A (en) * 1991-08-26 2000-02-29 3M Innovative Properties Company Powder dispenser
EP0477222B1 (en) * 1989-06-16 2000-08-16 Leiras Oy Device for more effective pulverization of a powdered inhalation medicament
WO2001000262A1 (en) * 1999-06-23 2001-01-04 Cambridge Consultants Limited Inhalers
US6293279B1 (en) 1997-09-26 2001-09-25 Trudell Medical International Aerosol medication delivery apparatus and system
US20010029947A1 (en) * 1999-12-17 2001-10-18 Steve Paboojian Receptacles to facilitate the extraction of powders
US6345617B1 (en) 1997-09-26 2002-02-12 1263152 Ontario Inc. Aerosol medication delivery apparatus and system
US20030015191A1 (en) * 2001-04-26 2003-01-23 New England Pharmaceuticals, Inc. Metered dose delivery device for liquid and powder agents
US6575160B1 (en) 1997-08-07 2003-06-10 Art Slutsky Inhalation device
US6651655B1 (en) * 2000-01-18 2003-11-25 Quadrant Technologies Limited Inhaled vaccines
GB2390813A (en) * 2002-07-02 2004-01-21 Optinose As Nasal devices
US6715486B2 (en) 2000-02-01 2004-04-06 Quadrant Technologies Limited Dry powder inhaler
US20040206350A1 (en) * 2002-12-19 2004-10-21 Nektar Therapeutics Aerosolization apparatus with non-circular aerosolization chamber
US20050150492A1 (en) * 2003-04-09 2005-07-14 Nektar Therapeutics Aerosolization apparatus with air inlet shield
US20050279349A1 (en) * 1991-07-02 2005-12-22 Patton John S Method and device for delivering aerosolized medicaments
WO2006075184A1 (en) * 2005-01-14 2006-07-20 Britannia Pharmaceuticals Limited Apparatus and methods for providing dry powder medicament for inhalation
US7204246B1 (en) 2004-07-08 2007-04-17 Joseph Berinato Air self-contained oxygen inhaler
US20070151560A1 (en) * 2003-06-12 2007-07-05 Robert Price Delivery device for a powder aerosol
US20070154407A1 (en) * 2005-12-01 2007-07-05 Boehringer Ingelheim International Gmbh Inhaler and store for a dry medicament formulation and related methods and use thereof
US20090090355A1 (en) * 2002-05-02 2009-04-09 Pari Innovative Manufacturers Aerosol medication inhalation system
US20090159081A1 (en) * 2007-12-20 2009-06-25 Peter Stadelhofer Discharge device for nasal application
US20090211576A1 (en) * 2007-10-02 2009-08-27 Timo Lehtonen Safety and abuse deterrent improved device
US20100263666A1 (en) * 2007-05-23 2010-10-21 Ryoichi Nagata Test substance administration system for animal experiment
USRE43174E1 (en) 2000-04-11 2012-02-14 Trudell Medical International Aerosol delivery apparatus
US20120111324A1 (en) * 2007-10-22 2012-05-10 Board Of Regents, The University Of Texas System Dry Powder Drug Delivery Formulations, Methods of Use, and Devices Therefore
US20140137865A1 (en) * 2011-07-13 2014-05-22 Pharmaxis Ltd. Delivery devices
US8869794B1 (en) 2003-04-09 2014-10-28 Novartis Pharma Ag Aerosolization apparatus with capsule puncturing member
US9700689B2 (en) 2002-05-21 2017-07-11 Trudell Medical International Medication delivery apparatus and system and methods for the use and assembly thereof
CN111386137A (en) * 2017-09-26 2020-07-07 株式会社新日本科学 Intranasal delivery device
US10786637B2 (en) 2011-07-13 2020-09-29 Pharmaxis Ltd. Delivery devices
RU209001U1 (en) * 2021-10-19 2022-01-26 Анатолий Анатольевич Кутьев PORTABLE NEBULIZER

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2517482A (en) * 1949-04-09 1950-08-01 Sharp & Dohme Inc Inhaler
US2533065A (en) * 1947-03-08 1950-12-05 George V Taplin Micropulverized therapeutic agents
US2642063A (en) * 1948-07-31 1953-06-16 Frederick M Turnbull Inhaler
US2722935A (en) * 1949-03-22 1955-11-08 Robert E Thompson Powder dispenser
US2865370A (en) * 1957-09-06 1958-12-23 Birch & Gattone Inc Dispensing adaptor for disposable aerosol units
US2992645A (en) * 1958-05-06 1961-07-18 Benger Lab Ltd Disperser for powders
US3184115A (en) * 1962-05-07 1965-05-18 Meshberg Philip Aerosol dispensing package
US3236458A (en) * 1962-02-23 1966-02-22 Ramis Jean Aerosol apparatus
US3355071A (en) * 1966-02-23 1967-11-28 Avoset Company Color imparting dispenser for aerosol products
US3357427A (en) * 1965-04-21 1967-12-12 John M Wittke Aerosol introducer device for dispensing a measured charge of therapeutic composition into body cavities

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533065A (en) * 1947-03-08 1950-12-05 George V Taplin Micropulverized therapeutic agents
US2642063A (en) * 1948-07-31 1953-06-16 Frederick M Turnbull Inhaler
US2722935A (en) * 1949-03-22 1955-11-08 Robert E Thompson Powder dispenser
US2517482A (en) * 1949-04-09 1950-08-01 Sharp & Dohme Inc Inhaler
US2865370A (en) * 1957-09-06 1958-12-23 Birch & Gattone Inc Dispensing adaptor for disposable aerosol units
US2992645A (en) * 1958-05-06 1961-07-18 Benger Lab Ltd Disperser for powders
US3236458A (en) * 1962-02-23 1966-02-22 Ramis Jean Aerosol apparatus
US3184115A (en) * 1962-05-07 1965-05-18 Meshberg Philip Aerosol dispensing package
US3357427A (en) * 1965-04-21 1967-12-12 John M Wittke Aerosol introducer device for dispensing a measured charge of therapeutic composition into body cavities
US3355071A (en) * 1966-02-23 1967-11-28 Avoset Company Color imparting dispenser for aerosol products

Cited By (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888252A (en) * 1974-01-23 1975-06-10 Anthony J Side Powder inhaler
US3998226A (en) * 1975-09-22 1976-12-21 Edward G. Gomez Inhalation device for encapsulated concentrates
EP0009667A1 (en) * 1978-09-11 1980-04-16 Michael T. Dr. Newhouse Inhalation device
US4940051A (en) * 1983-12-28 1990-07-10 Huhtamki Oy Inhalation device
US4841964A (en) * 1985-08-01 1989-06-27 Wilhelm Hurka Inhaler
US4796812A (en) * 1986-03-24 1989-01-10 L'oreal Device for preparing and dispensing a product consisting of two components and the corresponding process
US4921170A (en) * 1986-03-24 1990-05-01 L'oreal Device for preparing and dispensing a product consisting of two components and the corresponding process
US4687034A (en) * 1986-05-28 1987-08-18 Shell Oil Company Controlled release insert for a diesel fuel supply nozzle and method of adding a petroleum substrate over said insert
EP0271029A2 (en) * 1986-12-05 1988-06-15 Mect Corporation Inhaler
EP0271029A3 (en) * 1986-12-05 1989-05-31 Mect Corporation Inhaler
EP0377174A2 (en) * 1988-12-22 1990-07-11 Büsselmann, Manfred Method and apparatus for spraying and atomising liquids
EP0377174A3 (en) * 1988-12-22 1990-11-22 Büsselmann, Manfred Method and apparatus for spraying and atomising liquids
EP0477222B1 (en) * 1989-06-16 2000-08-16 Leiras Oy Device for more effective pulverization of a powdered inhalation medicament
US20050279349A1 (en) * 1991-07-02 2005-12-22 Patton John S Method and device for delivering aerosolized medicaments
US5161524A (en) * 1991-08-02 1992-11-10 Glaxo Inc. Dosage inhalator with air flow velocity regulating means
US6029661A (en) * 1991-08-26 2000-02-29 3M Innovative Properties Company Powder dispenser
US6119688A (en) * 1991-08-26 2000-09-19 3M Innovative Properties Company Powder dispenser
US5476093A (en) * 1992-02-14 1995-12-19 Huhtamaki Oy Device for more effective pulverization of a powdered inhalation medicament
US5460173A (en) * 1993-03-03 1995-10-24 Tenax Corporation Dry powder inhaler medicament carrier
US5388572A (en) * 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573A (en) * 1993-12-02 1995-02-14 Tenax Corporation Dry powder inhalator medicament carrier
US6575160B1 (en) 1997-08-07 2003-06-10 Art Slutsky Inhalation device
US6293279B1 (en) 1997-09-26 2001-09-25 Trudell Medical International Aerosol medication delivery apparatus and system
US6345617B1 (en) 1997-09-26 2002-02-12 1263152 Ontario Inc. Aerosol medication delivery apparatus and system
US6435177B1 (en) 1997-09-26 2002-08-20 Trudell Medical International Aerosol medication delivery apparatus and system
US7246617B1 (en) 1999-06-23 2007-07-24 Vectura Delivery Devices Limited Inhalers
WO2001000262A1 (en) * 1999-06-23 2001-01-04 Cambridge Consultants Limited Inhalers
JP2003503116A (en) * 1999-06-23 2003-01-28 ヴェクチュラ デリヴァリー デヴァイシス リミテッド Inhaler
US20010029947A1 (en) * 1999-12-17 2001-10-18 Steve Paboojian Receptacles to facilitate the extraction of powders
US6679256B2 (en) * 1999-12-17 2004-01-20 Nektar Therapeutics Systems and methods for extracting powders from receptacles
US6651655B1 (en) * 2000-01-18 2003-11-25 Quadrant Technologies Limited Inhaled vaccines
US6715486B2 (en) 2000-02-01 2004-04-06 Quadrant Technologies Limited Dry powder inhaler
US20040163644A1 (en) * 2000-02-01 2004-08-26 Gieschen Andrew W. Dry powder inhaler
US7958890B2 (en) 2000-02-01 2011-06-14 Quadrant Technologies Limited Dry powder inhaler
US20090084380A1 (en) * 2000-02-01 2009-04-02 Gieschen Andrew W Dry powder inhaler
US6971384B2 (en) 2000-02-01 2005-12-06 Quadrant Technologies Limited Dry powder inhaler
USRE43174E1 (en) 2000-04-11 2012-02-14 Trudell Medical International Aerosol delivery apparatus
USRE45068E1 (en) 2000-04-11 2014-08-12 Trudell Medical International Aerosol delivery apparatus
USRE46050E1 (en) 2000-04-11 2016-07-05 Trudell Medical International Aerosol delivery apparatus
US7025058B2 (en) 2001-04-26 2006-04-11 New England Pharmaceuticals, Inc. Metered dose delivery device for liquid and powder agents
US20030015191A1 (en) * 2001-04-26 2003-01-23 New England Pharmaceuticals, Inc. Metered dose delivery device for liquid and powder agents
US9308335B2 (en) 2002-05-02 2016-04-12 Pre Holding, Inc. Aerosol medication inhalation system
US8973571B1 (en) 2002-05-02 2015-03-10 Pre Holding, Inc. Aerosol medication inhalation system
US20090090355A1 (en) * 2002-05-02 2009-04-09 Pari Innovative Manufacturers Aerosol medication inhalation system
US8459252B2 (en) 2002-05-02 2013-06-11 Pari Innovative Manufacturers, Inc. Aerosol medication inhalation system
US7562656B2 (en) 2002-05-02 2009-07-21 Hydrate, Inc. Aerosol medication inhalation system
US8074641B2 (en) 2002-05-02 2011-12-13 Pre Holdings, Inc. Aerosol medication inhalation system
US9700689B2 (en) 2002-05-21 2017-07-11 Trudell Medical International Medication delivery apparatus and system and methods for the use and assembly thereof
US9814849B2 (en) 2002-05-21 2017-11-14 Trudell Medical International Medication delivery apparatus and system and methods for the use and assembly thereof
US10881816B2 (en) 2002-05-21 2021-01-05 Trudell Medical International Medication delivery apparatus and system and methods for the use and assembly thereof
GB2390813B (en) * 2002-07-02 2004-12-22 Optinose As Nasal devices
GB2390813A (en) * 2002-07-02 2004-01-21 Optinose As Nasal devices
US20040206350A1 (en) * 2002-12-19 2004-10-21 Nektar Therapeutics Aerosolization apparatus with non-circular aerosolization chamber
US20090260623A1 (en) * 2003-04-09 2009-10-22 Novartis Pharma Ag Aeorosolization apparatus with air inlet shield
US8069851B2 (en) 2003-04-09 2011-12-06 Novartis Ag Aeorosolization apparatus with air inlet shield
USRE47526E1 (en) 2003-04-09 2019-07-23 BGP Products Aerosolization apparatus with air inlet shield
US7559325B2 (en) 2003-04-09 2009-07-14 Novartis Pharma Ag Aerosolization apparatus with air inlet shield
US8869794B1 (en) 2003-04-09 2014-10-28 Novartis Pharma Ag Aerosolization apparatus with capsule puncturing member
US20050150492A1 (en) * 2003-04-09 2005-07-14 Nektar Therapeutics Aerosolization apparatus with air inlet shield
US20070151560A1 (en) * 2003-06-12 2007-07-05 Robert Price Delivery device for a powder aerosol
US7204246B1 (en) 2004-07-08 2007-04-17 Joseph Berinato Air self-contained oxygen inhaler
WO2006075184A1 (en) * 2005-01-14 2006-07-20 Britannia Pharmaceuticals Limited Apparatus and methods for providing dry powder medicament for inhalation
US20070154407A1 (en) * 2005-12-01 2007-07-05 Boehringer Ingelheim International Gmbh Inhaler and store for a dry medicament formulation and related methods and use thereof
US10293123B2 (en) * 2007-05-23 2019-05-21 Shin Nippon Biomedical Laboratories, Ltd. Test substance administration system for animal experiment
US20100263666A1 (en) * 2007-05-23 2010-10-21 Ryoichi Nagata Test substance administration system for animal experiment
US20090211576A1 (en) * 2007-10-02 2009-08-27 Timo Lehtonen Safety and abuse deterrent improved device
US8597616B2 (en) * 2007-10-22 2013-12-03 Board Of Regents Of The University Of Texas System Dry powder drug delivery formulations, methods of use, and devices therefore
US20120111324A1 (en) * 2007-10-22 2012-05-10 Board Of Regents, The University Of Texas System Dry Powder Drug Delivery Formulations, Methods of Use, and Devices Therefore
US8567390B2 (en) * 2007-12-20 2013-10-29 Aptar Radolfzell Gmbh Discharge device for nasal application
US20090159081A1 (en) * 2007-12-20 2009-06-25 Peter Stadelhofer Discharge device for nasal application
KR20140074277A (en) * 2011-07-13 2014-06-17 파맥시스 엘티디 Improvements relating to delivery devices
US20140137865A1 (en) * 2011-07-13 2014-05-22 Pharmaxis Ltd. Delivery devices
US9795748B2 (en) * 2011-07-13 2017-10-24 Pharmaxis Ltd. Delivery devices
US10786637B2 (en) 2011-07-13 2020-09-29 Pharmaxis Ltd. Delivery devices
CN111386137A (en) * 2017-09-26 2020-07-07 株式会社新日本科学 Intranasal delivery device
US11744967B2 (en) * 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
RU209001U1 (en) * 2021-10-19 2022-01-26 Анатолий Анатольевич Кутьев PORTABLE NEBULIZER

Similar Documents

Publication Publication Date Title
US3809084A (en) Pressurized portable dispenser
US3653380A (en) Aerosol powder dosage dispensing device
US3888253A (en) Device for administration of medicines
US5787881A (en) Inhalation device
US6983748B2 (en) Dry powder inhaler
EP0653946B1 (en) Low flow rate nebulizer
US4570630A (en) Medicament inhalation device
CA1305001C (en) Inhalation device
US3897779A (en) Triamcinolone acetonide inhalation therapy
US6116239A (en) Inhalation device
US6003512A (en) Dust gun-aerosol generator and generation
KR940701282A (en) Methods and Devices for Delivering Aerosolized Agents
RU2089227C1 (en) Apparatus for effective spraying of agglomerates formed in dose of powder drug preparation adapted to be introduced into patient's lungs
PT1294421E (en) Dry powder inhaler
HU209475B (en) Device for the administration of powdered medicinal substances
JP2006527046A (en) Powder aerosol feeder
JP2927464B2 (en) Aerosol device
IL111254A0 (en) Powder inhalers
JPS61179158A (en) Dispensing method and/or dispenser
EP2001535A1 (en) Inhaler flow channel
FR2352556A1 (en) Nasal and oral powder inhaler for medicines etc. - uses cyclone chamber to entrain powder into air stream
US20100006095A1 (en) Apparatus and methods for providing dry powder medicament for inhalation
JP2009531070A (en) Powder aerosol feeder
US2653608A (en) Insufflator
WO2008156381A1 (en) Inhaler for powder drug administration